price
RX
NASDAQ · RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
Healthcare · Biotechnology
$3.63
Up+$0.19 (+5.52%)
Updated Sep 5, 2026, 6:57 PM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.83B
- P/E ratio
- -2.94
- Dividend yield
- 0.00%
- 52-week range
- $2.77 – $7.18
- Volume
- 29.04M
- Avg. volume
- 43.4M
Price performance
RXRX price history
1M range · 21 trading sessions · Daily adjusted prices
RXRX closed at $3.63 after 21 trading sessions, up 12.73% for the selected period.
- Last close
- $3.63
- Period change
- +12.73%
- Period low
- $3.09
- Period high
- $3.63
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 4, 2026 | $3.415 | $3.70 | $3.41 | $3.63 | 29.04M |
| Sep 3, 2026 | $3.435 | $3.45 | $3.2901 | $3.44 | 13.75M |
| Sep 2, 2026 | $3.34 | $3.4891 | $3.285 | $3.38 | 14.05M |
| Sep 1, 2026 | $3.34 | $3.38 | $3.2801 | $3.33 | 10M |
| Aug 31, 2026 | $3.305 | $3.41 | $3.25 | $3.40 | 13.91M |
| Aug 28, 2026 | $3.40 | $3.45 | $3.31 | $3.34 | 10.56M |
| Aug 27, 2026 | $3.515 | $3.5499 | $3.42 | $3.44 | 10.99M |
| Aug 26, 2026 | $3.51 | $3.55 | $3.43 | $3.49 | 12.98M |
| Aug 25, 2026 | $3.27 | $3.59 | $3.26 | $3.56 | 22.52M |
| Aug 24, 2026 | $3.42 | $3.44 | $3.215 | $3.25 | 15.16M |
| Aug 21, 2026 | $3.39 | $3.6299 | $3.37 | $3.50 | 22.9M |
| Aug 20, 2026 | $3.40 | $3.46 | $3.27 | $3.34 | 21.45M |
| Aug 19, 2026 | $3.275 | $3.50 | $3.19 | $3.50 | 30.37M |
| Aug 18, 2026 | $3.03 | $3.10 | $2.92 | $3.09 | 16.35M |
| Aug 17, 2026 | $3.12 | $3.16 | $3.08 | $3.11 | 10.62M |
| Aug 14, 2026 | $3.30 | $3.305 | $3.14 | $3.16 | 10.55M |
| Aug 13, 2026 | $3.31 | $3.35 | $3.27 | $3.31 | 10.7M |
| Aug 12, 2026 | $3.37 | $3.38 | $3.26 | $3.29 | 10.31M |
| Aug 11, 2026 | $3.32 | $3.42 | $3.27 | $3.35 | 11.01M |
| Aug 10, 2026 | $3.20 | $3.36 | $3.19 | $3.29 | 14.03M |
| Aug 7, 2026 | $3.2541 | $3.265 | $3.18 | $3.22 | 9.36M |
Latest RXRX news
The latest Smart Investors Daily articles mentioning RXRX.
Stock researchResearch & News · Competitors
Loading stock research…